The restricted cellular host range of human herpesvirus 8

AIDS

Volumn 14, Issue 9, 2000, Pages 1123-1133

  Blackbourn, David J ^a   Lennette, Evelyne ^b   Klencke, Barbara ^a   Moses, Ashlee ^c   Chandran, Bala ^d   Weinstein, Mark ^e   Glogau, Richard G ^a   Witte, Marlys H ^f   Dennis, Way ^f   Kutzkey, Tim ^a   Herndier, Brian ^a   Levy, Jay A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Virolab Inc   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^e General Hospital   (United States)

^f UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

B cell; Cellular host range; Human herpesvirus 8; Kaposi's sarcoma

Indexed keywords

ARTICLE; B LYMPHOCYTE; BIOPSY; CELL CULTURE; CELL LINE; CELL TRANSFORMATION; CLINICAL ARTICLE; DISEASE PREDISPOSITION; EPSTEIN BARR VIRUS; HOST CELL; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; MACROPHAGE; MONONUCLEAR CELL; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; VIRUS TRANSFORMATION; WART VIRUS;

ADULT; ANIMALS; B-LYMPHOCYTES; CELL LINE, TRANSFORMED; COCULTURE TECHNIQUES; ENDOTHELIUM, VASCULAR; EPITHELIAL CELLS; FETAL BLOOD; HERPESVIRUS 8, HUMAN; HUMANS; INFANT, NEWBORN; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES; LYMPHOMA; MACROPHAGES; ORGAN SPECIFICITY; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; SARCOMA, KAPOSI; TUMOR CELLS, CULTURED;

EID: 0033933683     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200006160-00009     Document Type: Article

References (66)

1. 1. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma [see comments]. Science 1994, 266:1865-1869.
2. 2. Ambroziak JA, Blackbourn DJ, Herndier BG, et al. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients [letter; comment]. Science 1995, 268:582-583.
3. 3. Cao SJ, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma [see comments]. Nature Med 1996, 2:925-928.
4. 4. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission [see comments] [published erratum appears in Nature Med 1996, 2:1041]. Nature Med 1996, 2:918-924.
5. 5. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients [see comments]. Lancet 1996, 348:858-861.
6. 6. Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by anti-bodies to recombinant capsid protein and latent immunofluores-cence antigen [see comments]. Lancet 1996, 348:1133-1138.
7. 7. Rainbow L, Platt GM, Simpson GR, et al. The 222-to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by ORF73 and is a component of the latency-associated nuclear antigen. J Virol 1997, 71:5915-5921.
8. 8. Zhu L, Wang R, Sweat A, Goldstein E, Horvat R, Chandran B. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells. Virology 1999, 256:381-392.
9. 9. Boshoff C, Schulz TF, Kennedy MM, et al. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nature Med 1995, 1:1274-1278.
10. 10. Sturzl M, Blasig C, Schreier A, et al. Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma. Int J Cancer 1997, 72:68-71.
11. 11. Dupin N, Fisher C, Kellam P, et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multi-centric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci USA 1999, 96:4546-4551.
12. 12. Blasig C, Zietz C, Haar B, et al. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. I Virol 1997, 71:7963-7968.
13. 13. Monini P, Colombini S, Sturzl M, et al. Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood 1999, 93:4044-4058.
14. 14. Gao SJ, Boshoff C, Jayachandra S, Weiss RA, Chang Y, Moore PS. KSHV ORFK9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene 1997, 15:1979-1985.
15. 15. Bais C, Santomasso B, Coso O, et al. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator [see comments] (published erratum appears in Nature 1998, 392:2101. Nature 1998, 391:86-89.
16. 16. Lee H, Veazey R, Williams K, et al. Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nature Med 1998, 4:435-440.
17. 17. Muralidhar S, Pumfery AM, Hassani M, et al. Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene. J Virol 1998, 72:4980-4988.
18. 18. Lagunoff M, Majeti R, Weiss A, Ganem D. Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci USA 1999, 96: 5704-5709.
19. 19. Renne R, Blackbourn D, Whitby D, Levy J, Ganem D. Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells. J Virol 1998, 72:5182-5188.
20. 20. Flore O, Rafii S, Ely S, O'Leary JJ, Hyjek EM, Cesarman E. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature 1998, 394:588-592.
21. 21. Moses AV, Fish KN, Ruhl R, et al. Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. J Virol 1999, 73:6892-6902.
22. 22. Sirianni MC, Uccini S, Angeloni A, Faggioni A, Cottoni F, Ensoli B. Circulating spindle cells: correlation with human herpesvirus-8 (HHV-8) infection and Kaposi's sarcoma [letter]. Lancet 1997, 349:255.
23. 23. Davis MA, Sturzl MA, Blasig C, et al. Expression of human herpesvirus 8-encoded cyclin D in Kaposi's sarcoma spindle cells [see comments], J Natl Cancer Inst 1997, 89:1868-1874.
24. 24. Mesri EA, Cesarman E, Arvanitakis L, et al. Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J Exp Med 1996, 183:2385-2390.
25. 25. Blackbourn DJ, Ambroziak J, Lennette E, Adams M, Ramachandran B, Levy JA. Infectious human herpesvirus 8 in a healthy North American blood donor [see comments]. Lancet 1997, 349:609-611.
26. 26. Moore PS, Gao SJ, Dominguez G, et al. Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae [published erratum appears in J Virol 1996, 70:9083]. J Virol 1996, 70:549-558.
27. 27. Friborg Jr, J, Kong WP, Flowers CC, et al. Distinct biology of Kaposi's sarcoma-associated herpesvirus from primary lesions and body cavity lymphomas. J Virol 1998, 72:10073-10082.
28. 28. Kliche S, Kremmer E, Hammerschmidt W, Koszinowski U, Haas J. Persistent infection of Epstein-Barr virus-positive B lymphocytes by human herpesvirus 8. J Virol 1998, 72:8143-8149.
29. 29. Foreman KE, Friborg Jr, J, Kong WP, et al. Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma [see comments]. N Engl J Med 1997, 336:163-171.
30. 30. Nador RG, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996, 88:645-656.
31. 31. Levy JA, Tobler LH, McHugh TM, Casavant CH, Stites DP. Long-term cultivation of T-cell subsets from patients with acquired immune deficiency syndrome. Clin Immunol Immunopathol 1985, 35:328-336.
32. 32. Castro BA, Weiss CD, Wiviott LD, Levy JA. Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells, J Clin Microbiol 1988, 26:2371-2376.
33. 33. Barker E, Bossart KN, Fujimura SH, Levy JA. CD28 costimulation increases CD8+ cell suppression of HIV replication. J Immunol 1997, 159:5123-5131.
34. 34. Levy JA. Xenotropic type C viruses. Curr Top Microbiol Immunol 1978, 79:111-213.
35. 35. Schmelz M, Way DL, Borgs P, et al. A novel type of adhering junction in an epithelioid tumorigenic rat cell culture line. Cell Tissue Res 1998, 294:11-25.
36. 36. Blackbourn DJ, Herndier BG, Levy JA. Characterization of cell lines derived from fibromatous tumors of a human immunodeficiency virus type 2-infected baboon. Presented at the American Association for Cancer Research. Toronto, Canada 1995.
37. 37. Locher CP, Barnett SW, Herndier BG, et al. Human immunodeficiency virus-2 infection in baboons is an animal model for human immunodeficiency virus pathogenesis in humans. Arch Pathol Lab Med 1998, 122:523-533.
38. 38. Barnett SW, Murthy KK, Herndier BG, Levy JA. An AIDS-like condition induced in baboons by HIV-2. Science 1994, 266:642-646.
39. 39. Kaur P, McDougall JK. HPV-18 immortalization of human keratinocytes. Virology 1989, 173:302-310.
40. 40. Renne R, Zhong W, Herndier B, et al. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nature Med 1996, 2:342-346.
41. 41. Said JW, Chien K, Tasaka T, Koeffler HP. Ultrastructural characterization of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) in Kaposi's sarcoma lesions: electron microscopy permits distinction from cytomegalovirus (CMV). J Pathol 1997, 182:273-281.
42. 42. Blackbourn DJ, Fujimura SH, Chandran B, Kutzkey T, Zhu L, Levy J. Human herpesvirus 8 (HHV-8) replication measured by flow cytometry. Presented at the American Association of Cancer Research Annual Meeting. Philadelphia, USA 1999.
43. 43. Chan SR, Bloomer C, Chandran B. Identification and characterization of human herpesvirus-8 lytic cycle-associated ORF59 protein and the encoding cDNA by monoclonal antibody. Virology 1998, 240:118-126.
44. 44. Chandran B, Bloomer C, Chan SR, Zhu L, Goldstein E, Horvat R. Human herpesvirus-8 ORFK8.1 gene encodes immunogenic glycoproteins generated by spliced transcripts. Virology 1998, 249:140-149.
45. 45. Blackbourn DJ, Chuang LF, Sutjipto S, et al. Detection of simian immunodeficiency virus RNA from infected rhesus macaques by the polymerase chain reaction. J Virol Methods 1992, 37: 109-117.
46. 46. Sambrook J, Fritsch, E. F., Maniatis, T. Molecular Cloning: a Laboratory Manual. 2nd edn. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1989.
47. 47. Zhong W, Wang H, Herndier B, Ganem D. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc Natl Acad Sci USA 1996, 93:6641-6646.
48. 48. Russo JJ, Bohenzky RA, Chien MC, et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci USA 1996, 93:14862-14867.
49. 49. Walls EV, Crawford DH. Generation of B lymphoblastoid cell lines using Epstein-Barr virus. In Lymphocytes: a Practical Approach. Edited by Klauss GGB. Oxford, Washington DC: IRL Press; 1987:149-162.
50. 50. Orenstein JM, Alkan S, Blauvelt A, et al. Visualization of human herpesvirus type 8 in Kaposi's sarcoma by light and transmission electron microscopy. AIDS 1997, 11:F35-F45.
51. 51. Hayward GS. KSHV strains: the origins and global spread of the virus. Semin Cancer Biol 1999, 9:187-199.
52. 52. Blackbourn DJ, Ambroziak JA, Lennette ET, Northfelt DW, Glogau RG, Levy JA. The novel herpesvirus-like DNA sequences detected in Kaposi's sarcoma correlate with an infectious agent. Presented at the American Association for Cancer Research. Washington DC, USA 1996.
53. 53. Huang YQ, Li JJ, Poiesz BJ, Kaplan MH, Friedman-Kien AE. Detection of the herpesvirus-like DNA sequences in matched specimens of semen and blood from patients with AIDS-related Kaposi's sarcoma by polymerase chain reaction in situ hybridization. Am J Pathol 1997, 150:147-153.
54. 54. Sirianni MC, Vincenzi L, Topino S, et al. Human herpesvirus 8 DNA sequences in CD8+ T cells [letter; comment]. J Infecf Dis 1997, 176:541.
55. 55. Kieff, E. Epstein-Barr virus and its replication. In Virology. Edited by Fields BN, Knipe DM, Howley PM. Philadelphia: Lippincott-Raven Press; 1996, 1109-1162.
56. 56. Ballestas ME, Chatis PA, Kaye KM. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 1999, 284:641-644.
57. 57. Rawlins DR, Milman G, Hayward SD, Hayward GS. Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region. Cell 1985, 42:859-868.
58. 58. Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985, 43:831-840.
59. 59. Kaye KM, Izumi KM, Kieff E. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA 1993, 90:9150-9154.
60. 60. Eliopoulos AG, Rickinson AB. Epstein-Barr virus: LMP1 masquerades as an active receptor. Curr Biol 1998, 8:R196-R198.
61. 61. Trivedi P, Masucci MG, Winberg G, Klein G. The Epstein-Barr-virus-encoded membrane protein LMP but not the nuclear antigen EBNA-1 induces rejection of transfected murine mammary carcinoma cells. Int J Cancer 1991, 48:794-800.
62. 62. Zheng X, Yuan F, Hu L, Chen F, Klein G, Christensson B. Effect of beta-lymphocyte-and NPC-derived EBV-LMP1 gene expression on in vitro growth and differentiation of human epithelial cells. Int J Cancer 1994, 57:747-753.
63. 63. Strobl LJ, Hofelmayr H, Stein C, et al. Both Epstein-Barr viral nuclear antigen 2 (EBNA2) and activated Notch1 transactivate genes by interacting with the cellular protein RBP-J kappa. Immunobiology 1997, 198:299-306.
64. 64. Herndier BG, Werner A, Arnstein P, et al. Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals. AIDS 1994, 8:575-581.
65. 65. Banchereau J, de Paoli P, Valle A, Garcia E, Rousset F. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 1991, 251:70-72.
66. 66. Rixon FJ, McLauchlan J. Herpes simplex virus vectors. In Molecular Virology: a Practical Approach. Edited by Davison AJ, Elliott RM. Oxford, New York: IRL Press; 1993:286-307.